The Role of Imaging in the Active Surveillance of Small Renal Masses

Wagstaff, Peter G. K.; Zondervan, Patricia J.; Rosette, Jean J.M.C.H. de la; Laguna, M. Pilar

doi:10.1007/s11934-013-0386-x

Cited by 21 publications

(14 citation statements)

References 61 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In renal cancer, this is currently defined by lesion size alone, although other characteristics are also being considered to determine eligibility for surveillance of small renal masses [23]. In renal cancer, this is currently defined by lesion size alone, although other characteristics are also being considered to determine eligibility for surveillance of small renal masses [23].…”

Section: Using Mri To Assess Men During Follow-up On Surveillancementioning

confidence: 99%

Can MRI replace serial biopsies in men on active surveillance for prostate cancer?

Moore

Petrides

Emberton

2014

Current Opinion in Urology

View full text Add to dashboard Cite

show abstract

Section: Using Mri To Assess Men During Follow-up On Surveillancementioning

confidence: 99%

Can MRI replace serial biopsies in men on active surveillance for prostate cancer?

Moore

Petrides

Emberton

2014

Current Opinion in Urology

View full text Add to dashboard Cite

show abstract

“…Lanzman et al initially observed encouraging results in a prospective cohort of 34 patients that demonstrated notable differences in the perfusion properties of RCCs compared with oncocytomas. The authors also suggested ASL as a means for differentiating some of the RCC subtypes, as the papillary variant had significantly lower perfusion on ASL than the other subtypes examined [58,59]. Other studies have shown similarly promising results for perfusion imaging to differentiate RCC subtypes.…”

Section: Magnetic Resonance Imagingmentioning

confidence: 90%

Imaging of renal cell carcinoma

Sankineni

Brown

Cieciera

et al. 2016

Urologic Oncology: Seminars and Original Investigations

View full text Add to dashboard Cite

“…70 First, most SRMs have low malignant potential, with 15–20% showing benign histology. Of the remaining ~80%, only about 25% have aggressive pathologic characteristics.…”

Section: Renal Cell Carcinomamentioning

confidence: 99%

Evaluation and Management of the Geriatric Urologic Oncology Patient

McKibben

Smith

2014

Curr Geri Rep

View full text Add to dashboard Cite

The geriatric population presents a unique set of challenges in urologic oncology. In addition to the known natural history of disease, providers must also consider patient factors such as functional and nutritional status, comorbidities and social support when determining the treatment plan. The development of frailty measures and biomarkers to estimate surgical risk shows promise, with several assessment tools predictive of surgical complications. Decreased dependence on chronologic age is important when assessing surgical fitness, as age cutoffs prevent appropriate treatment of many elderly patients who would benefit from surgery. Within bladder, kidney and prostate cancers, continued refinement of surgical techniques offers a broader array of options for the geriatric patient than previously available.

show abstract

The Role of Imaging in the Active Surveillance of Small Renal Masses

Cited by 21 publications

References 61 publications

Can MRI replace serial biopsies in men on active surveillance for prostate cancer?

Can MRI replace serial biopsies in men on active surveillance for prostate cancer?

Imaging of renal cell carcinoma

Evaluation and Management of the Geriatric Urologic Oncology Patient

Contact Info

Product

Resources

About